On June 26, 2024, Masimo Corporation announced that it has filed an investor presentation with shareholders, stating that its robust track record of innovation, led by Joe Kiani, that supports Company?s longstanding valuation premium to industry peers, strategic initiatives for sustained growth and margin expansion that are expected to more than double adjusted EPS to ~$8 by 2029; and it?s belief that Politan?s value-destructive agenda to oust Kiani and take control of Masimo without paying a premium or articulating an exercisable plan poses a significant risk to the value of the Company. In addition, the Company recommended the shareholders to vote for its board nominees Joe Kiani and Christopher Chavez.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.9 USD | -4.23% |
|
-3.99% | +7.45% |
27/06 | Masimo and Cleveland Clinic Collaborate to Improve Hospital Remote Care | CI |
26/06 | Masimo Files Investor Presentation with Shareholders | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.45% | 6.69B | |
+75.69% | 12.57B | |
-28.45% | 6.98B | |
+8.73% | 5.18B | |
-19.73% | 4.63B | |
+17.40% | 4.18B | |
-21.37% | 3.81B | |
-25.83% | 2.8B | |
-1.24% | 2B | |
+14.74% | 1.84B |
- Stock Market
- Equities
- MASI Stock
- News Masimo Corporation
- Masimo Files Investor Presentation with Shareholders